Interdisciplinary Autoimmune Summit

Clinicians should be aware of racial and cultural differences in the perception of health care and tailor their approach accordingly, and reduce potential health care disparities, noted a speaker at the 2021 Interdisciplinary Autoimmune Summit.

Janus kinase inhibitors “may prove useful” in a wider range of immune-mediated inflammatory diseases, including refractory cutaneous dermatomyositis, chronic plaque psoriasis and other conditions, according to a speaker here.

Anti-COVID-19 antibody responses are attenuated in patients who receive infliximab for inflammatory bowel disease, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

Experimental studies indicate that sleep loss can lead to elevated concentrations of proinflammatory cytokines and enhance the perception of pain among patients with immune-mediated inflammatory diseases, according to a speaker here.

The combined “derm-rheum” clinic offers a unique opportunity to streamline care and improve drug access for patients with psoriatic arthritis while enhancing cross-disciplinary education among dermatologists and rheumatologists, noted a speaker at a recent summit.

Emerging data are beginning to show that COVID-19 can induce autoimmunity in patients without preexisting immune-mediated inflammatory diseases, with consequences that are yet unknown, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

The U.S. public health community was unable to foresee the rampant politicization of the COVID-19 pandemic, and was shocked by the initial federal response, according to New York Times bestselling author John M. Barry.

The ability to identify the features of Sjögren’s syndrome, and to seek payer approval for specific manifestations of the disease, is of paramount importance for the rheumatologist, according to a presenter at the 2021 Interdisciplinary Autoimmune Summit.